CLIP score as a prognostic indicator for hepatocellular carcinoma: Experience with patients in the Middle East

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 7, 2004, Pages 675-680

  Siddique, Iqbal ^a,b   El Naga, Hisham Abu ^b   Memon, Anjum ^a,c   Thalib, Lukman ^a   Hasan, Fuad ^a   Al Nakib, Basil ^a,b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c KUWAIT CANCER CONTROL CENTER   (Kuwait)

Author keywords

Cancer of the Liver Italian Programme score; Hepatocellular carcinoma; Kuwait; Middle East; Okuda stage; Primary liver cancer; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; FEMALE; HAZARD ASSESSMENT; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE EAST; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DEVELOPING COUNTRIES; FEMALE; HUMANS; KUWAIT; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 3142554210     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000108338.41221.ec     Document Type: Article

References (24)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:1253-1257.
2. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
3. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928.
4. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27:1578-1583.
5. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 1995; 109:917-922.
6. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997; 8:117-136.
7. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28:751-755.
8. Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999; 31:133-141.
9. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-338.
10. Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94:1760-1769.
11. The Cancer of the Liver Italian Program (CLIP) investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31:840-845.
12. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000; 89:2266-2273.
13. Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002; 50:881-885.
14. Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34:529-534.
15. Kouroumalis EA, Skordilis PG, Moschandrea J, Alexandrakis G, Charoulakis N, Tzardi M, et al. Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virus. Eur J Gastroenterol Hepatol 1997; 9:981-988.
16. Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol 1998; 21:386-391.
17. Gulf Cooperation Council Countries, Cancer Incidence Report. Saudi Arabia: Gulf Center for Cancer Registration; 1998.
18. Atiyeh M, Ali MA. Primary hepatocelluar carcinoma in Saudi Arabia. A clinicopathological study of 54 cases. Am J Gastroenterol 1980; 74: 25-29.
19. Kingston M, Ali MA, Lewall D. Hepatic tumors in Saudi Arabia. A practical approach to diagnosis. Cancer 1985; 55:1579-1585.
20. Ashraf SJ, Arya SC, el Sayed M, Sahay R, Parande CM, Tajuddin MR, et al. A profile of primary hepatocellular carcinoma patients in the Gizan Area of Saudi Arabia. Cancer 1986; 58:2163-2168.
21. Chen DS, Sung JL. Serum alphafetoprotein in hepatocellular carcinoma. Cancer 1977; 40:779-783.
22. Ruoslahti E, Salaspuro M, Pihko H, Andersson L, Seppala M. Serum alpha-fetoprotein: diagnostic significance in liver disease. Br Med J 1974; ii:527-529.
23. Hamy A, Savigny JL, Paineau J, N'Guyen JM, Mirallie E, Visset J. Uni- and multivariate analysis of predictive survival factors in hepatocellular carcinoma. A study of a series of 122 patients. J Chir (Paris) 1997; 134:417-422.
24. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77:2217-2222.